Envision Healthcare
EVHC
Delayed Nyse - 10/20 10:03:00 pm
45.13USD
+0.11%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 6967 895
EBITDA6311 025
Operating profit (EBIT)568923
Pre-Tax Profit (EBT)--
Net income-27,7-28,8
EPS ( $ )-0,470,18
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5076 471
Finance--
Operating income (EBITDA)6311 025
Leverage
(Debt/EBITDA)
8,73x6,31x
Capital Expenditure99,5131
Book Value Per Share (BVPS)57,3 $58,5 $
Cash Flow per Share6,66 $6,40 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 5 453 M$ -
Entreprise Value (EV) 11 924 M$ 10 475 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 257x 15,1x
Capitalization / Revenue 0,69x 0,63x
EV / Revenue 1,51x 1,21x
EV / EBITDA 11,6x 9,06x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,77x 0,74x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 11,7% 12,2%
operating Leverage (Delta EBIT / Delta Sales) 0,55x 1,52x
Net Margin (Net Profit / Revenue) -0,36% 4,05%
ROA (Net Profit / Asset) 2,10% 2,60%
ROE (Net Profit / Equities) 5,79% 6,05%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,66% 0,92%
Cash Flow / Sales 9,79% 7,43%
Capital Intensity (Assets / Sales) -0,17x 1,56x
Financial Leverage (Net Debt / EBITDA) 6,31x 4,34x
Price Earning Ratio
BNA & Dividende